SCHEMBL7819210

SCHEMBL7819210

Clc1cccc(-c2[c]cccc2)c1.[c]1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
IDO1 P14902 2/20 0.37
SCN2A Q99250 1/20 0.37
ADORA2A P29274 3/20 0.37
ADORA1 P30542 3/20 0.37
ADORA2B P29275 1/20 0.37
ALOX5 P09917 1/20 0.37
SOS1 Q07889 1/20 0.36
PGR P06401 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2115007 0.93 NPC1 (0.42) NPC1TP53TSHRNFKB1RAB9A
SCHEMBL27998968 0.89 ALOX5 (0.43) NPC1TP53TSHRNFKB1RAB9A
SCHEMBL7812292 0.80 CYP1A2 (0.46) NPC1TSHRRAB9ASMN1; SMN2SCN2A
SCHEMBL7815866 0.79 AHR (0.43) NPC1RAB9AIDO1ADORA1
SCHEMBL26567 0.77 MAOA (0.41) ALOX5MEN1KMT2A
SCHEMBL589437 0.77 MAOA (0.41) ALOX5MEN1KMT2A
SCHEMBL7180814 0.77 TSHR (0.35) TSHRSMN1; SMN2ADORA2AADORA1ADORA2B
SCHEMBL7459587 0.77 TAAR1 (0.44) NPC1TP53TSHRNFKB1RAB9A
SCHEMBL9732385 0.77 TSHR (0.44) NPC1TP53TSHRNFKB1RAB9A
SCHEMBL7982316 0.77 MEN1 (0.34) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GmbH (DE) 2001-05-16 EP disclosed
WO-2000004011-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDAEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2000-01-27 WO disclosed